Evaluasi Penggunaan Obat Pada Pasien Penyakit Jantung Koroner Di Instalasi Rawat Inap RSUD Raden Mattaher Jambi
Keywords:
Kata kunci, DRPs, Penyakit Jantung Koroner, RSUD Raden Mattaher Jambi.Abstract
Abstrak
Penyakit jantung koroner adalah suatu keadaan yang diakibatkan oleh adanya penyempitan dan penyumbatan pembuluh darah yang mengalirkan darah ke otot jantung, sehingga otot jantung akan kekurangan darah dan tidak mendapatkan oksigen untuk pekerjaannya.Tujuan dari penelitian adalah untuk mengevaluasi ketepatan penggunaan obat yang diberikan, yang meliputi tepat indikasi, tepat obat, tepat dosis, tepat frekuensi dan interaksi obat. Penelitian ini merupakan penelitian deskriptif dengan pengambilan data secara retrospektif terhadap data rekam medik pasien yang memenuhi kriteria inklusi dan eksklusi. Hasil dari penelitian ini didapati sebanyak 42 data rekam medik pasien yang memenuhi kriteria dengan persentase ketepatan penggunaan obat terdiri dari tepat indikasi 100 %, tepat obat 85,71 %, tepat dosis 90,47 %, tepat frekuensi 100 %.
Â
Â
References
irmalita, Juzar A Datsanh, Andrianto SY budi. pedoman tatalaksana sindrom koronern aut. penghimpunan Dr kadiovaskular. 2015;ketiga.
Aini N, Kuncoro B, Yanti Y. Sekolah tinggi farmasi muhammadiyah tangerang. 2018;V(3).
Marleni L, Alhabib A. Faktor Risiko Penyakit Jantung Koroner di RSI SITI Khadijah Palembang. 2019;
Kawenglan sartika inrisari, Wiyono weny indayany, Mamarimbing M. Identifikasi Drug Related Problems ( DRP S ) Pada Tahap Administration Pasien Penyakit Jantung Koroner Prevalensi PJK untuk Sulawesi Utara. 2019;8(1):1–10.
Chusna S. pola penggunaan obat pada pasien penyakit jantung koroner rawat inap di rumah sakit A Kudus tahun 2012. 2015;3(2):54–67.
Rampengan SH, Jim EL. Gambaran penyakit jantung koroner pada pasien gagal jantung yang menjalani rawat inap di RSUP Prof . Dr . R . D . Kandou Manado. 2016;4(November).
Marwati D. Evaluasi Penggunaan Obat Pada Pasien Gagal Jantung Evaluasi Penggunaan Obat Pada Pasien Gagal Jantung Rawat Inap Di Rumah Sakit “ X †Tahun 2016. 2018;
RI D. Profil Kesehatan Republik Indonesia. 2009;
Taroreh GN et al. Evaluasi Penggunaan Obat Pada Pasien Dengan Penyakit. Pharmacon. 2017;6(4):55–66.
Kementrian Kesehatan. Pharmaceutical care penyakit cardiovascular. 2006;
zhang, Fang X M, K RZ. selective beta-1 blockers deteriorate glucose metabolisem. saudi med. 2014;165–71.
Untari EK, Agilina AR, Susanti R, Studi P, Fakultas F, Universitas K, et al. Evaluasi Rasionalitas Penggunaan Obat Antihipertensi di Puskesmas Siantan Hilir Kota Pontianak Tahun 2015 Evaluation on Rationality of Hypertension Treatment in Puskesmas Siantan Hilir Pontianak on 2015. 2018;5(1):32–9.
Priyanto. Farmakoterapi dan Terminologi Medis. jakarta: leskonfil; 2009.
Downloads
Published
Issue
Section
License
I. ORIGINALITY, AUTHORSHIP, AND COPYRIGHT
The manuscripts submitted for publication must be research works written in English that have not been previously published and  are not being considered for publication elsewhere. All the authors must have agreed to the submission and to the order of their names on the title page. They must also have agreed that the corresponding author may act on their behalf throughout the editorial review and publication process. The corresponding author is responsible for obtaining such agreement.
Requests for changes in authorship (order of listing or addition or deletion of names) after submission should be accompanied by signed statements of agreement from all the parties involved. To maintain and protect the publisher‘s ownership and rights and to protect the original authors from misappropriations of their published work, author(s) are required to sign a Journal Publishing Agreement and send it to the editorial office (jhtm@uui.ac.id).
II. PERMISSION
The author is responsible for acquiring the permission(s) to reproduce any copyrighted figures, tables, data, or text that are being used in the submitted paper. Authors should note that text quotations of more than 250 words from a published or copyrighted work will require grant of permission from the original publisher to reprint. The written permission letter(s) must be submitted together with the manuscript.
III. EDITORIAL REVIEW AND REVISION
All papers will be critically read by at least two anonymous reviewers, selected for their competence in the subject area of the paper. Acceptance of the paper will depend upon its scientific merit and suitability for the journal. A paper may be accepted in its original form or subject to revision.
The reviewers' (and editor's) suggestions will be conveyed to the author, who will then have an opportunity to revise the paper. A manuscript returned to an author for revision can be held for a maximum of eight weeks.
The accepted paper will be edited by native English speakers. The cost of language editing service is currently free.
IV. PROOFS
Galley proofs (PDF format) for an accepted article will be sent by e-mail to the corresponding author for copyediting corrections. The core content of an article cannot be changed at this time. It is the author's responsibility to check the entire manuscript, including tables, figure legends, and cited reference numbers, not just the items queried. The proofs should be corrected and mailed to the editorial office within 48 hours of receipt in order to expedite publication. Only one set of corrections will be accepted. In other words, it is important to ensure that all of your corrections are sent to us in one communication.
V. Â REPRINTS
Five free reprint copies of the published article will be shipped to the corresponding authors in Indonesia only, approximately two weeks after the issue is printed. Authors, including overseas authors, who wish to purchase reprints, are required to complete the Reprint Order Form, which will be sent with the galley proofs to corresponding authors. This form must be returned together with the corrected galley proofs.
